| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |